Factors influencing KI67 count in neuroendocrine tumors.
Miluska Castillo(Instituto Nacional de Enfermedades Neoplásicas), Tatiana Vidaurre(The University of Texas MD Anderson Cancer Center), Rosario Villa(Instituto Nacional de Enfermedades Neoplásicas), Luis Cano(Instituto Nacional de Enfermedades Neoplásicas), Valeria Villegas(Universidad Peruana Cayetano Heredia), Carolina B. López(Institute for Women's Policy Research), Marco Gálvez-Niño(Instituto Nacional de Enfermedades Neoplásicas), Sandro Casavilca‐Zambrano(Institute for Anthropological Research), Claudio Flores(EsSALUD), Carlos Castañeda Altamirano(Instituto Nacional de Enfermedades Neoplásicas), Juvenal Sánchez(Instituto Nacional de Enfermedades Neoplásicas), Carlos Carracedo Gonzáles(Instituto Nacional de Enfermedades Neoplásicas)
Cited by 0
Related Papers
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
|npj Breast Cancer|2021|282
Latin Americans show wide-spread Converso ancestry and imprint of local Native ancestry on physical appearance
|Nature Communications|2018|187
Malignant Gliomas with Primitive Neuroectodermal Tumor‐like Components: A Clinicopathologic and Genetic Study of 53 Cases
|Brain Pathology|2008|178